SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001399529-21-000033
Filing Date
2021-02-16
Accepted
2021-02-16 07:07:09
Documents
1
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 wf-form5_161347721171564.html 5  
1 FORM 5 wf-form5_161347721171564.xml 5 5005
  Complete submission text file 0001399529-21-000033.txt   6363
Mailing Address C/O SKYLINE VENTURES 525 UNIVERSITY AVE., SUITE 1350 PALO ALTO CA 94301
Business Address
HOFFMAN STEPHEN J (Reporting) CIK: 0001190418 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36281 | Film No.: 21632335

Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations